GLP-1/GIP RAs clinical guidance updated
Based on new evidence from clinical studies and to make recommendations clearer, clinical practice recommendations for patients taking GLP-1 RA and dual GLP-1/GIP RAs prior to anaesthesia or sedation have been updated.
Representatives from ANZCA, the Gastroenterological Society of Australia, the Australian Diabetes Society, and the National Association of Clinical Obesity Services and Australian and New Zealand Metabolic and the Obesity Surgery Society have developed the revised recommendations, which now include a decision-aid flowchart linked to explanatory statements.
They now also include a clear statement regarding the recommendation not to withhold these drugs prior to a procedure.
The revised document is available here. Please send any feedback or queries to [email protected]
You might also be interested in...
We’re searching for interested fellows to join the ANZCA and FPM Supervisor Support Project working group.
Moves by Health NZ to outsource elective operations to the private hospital sector increase the risk of a two-tier health system and will worsen the medical workforce shortage, a leading medical college has warned.
A digest of college news coverage for June/July 2025